Skip to content
Advertisement

FILE - In this April 3, 2021, file photo, a health worker prepares a dose of the AstraZeneca vaccine during a COVID-19 vaccination campaign in Pamplona, northern Spain. A patchwork of advice is emerging from governments across Europe and farther afield, a day after the European Union’s drug regulator said there was a “possible link” between the AstraZeneca vaccine and a rare clotting disorder. Regulators in the United Kingdom and the EU both stressed that the benefits of receiving the vaccine continue to outweigh the risks for most people. (AP Photo/Alvaro Barrientos, File)

FILE - In this April 3, 2021, file photo, a health worker prepares a dose of the AstraZeneca vaccine during a COVID-19 vaccination campaign in Pamplona, northern Spain. A patchwork of advice is emerging from governments across Europe and farther afield, a day after the European Union’s drug regulator said there was a “possible link” between the AstraZeneca vaccine and a rare clotting disorder. Regulators in the United Kingdom and the EU both stressed that the benefits of receiving the vaccine continue to outweigh the risks for most people. (AP Photo/Alvaro Barrientos, File)

Featured Photo Galleries